STAGE III VAGINAL CANCER AJCC V6 AND V7
Clinical trials for STAGE III VAGINAL CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III VAGINAL CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE III VAGINAL CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a drug combo boost survival in advanced cervical cancer?
Disease control OngoingThis study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky or advanced cancer will be randomly assigned to receive either standa…
Matched conditions: STAGE III VAGINAL CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo shows promise in early trial for advanced cervical and vaginal cancers
Disease control OngoingThis early-phase study tested an oral drug called triapine added to standard chemotherapy (cisplatin) and radiation for 21 people with advanced cervical or vaginal cancer. The goal was to find the safest dose and see how well the body absorbs the drug. While not a cure, the appro…
Matched conditions: STAGE III VAGINAL CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC